Electromed Inc
Research Electromed Inc (ELMD) on Bullrun: valuation model: 8.3% undervalued, market cap USD 231.66M, P/E 21.3. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerELMD
- ExchangeNYSE MKT
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Valuation signal8.3% undervalued
- Market capUSD 231.66M
- P/E21.3
- Financial periodFY2026
- RevenueUSD 73.78M
- Revenue growth15.3%
- Net incomeUSD 11.30M
- Free cash flowUSD 8.37M
- Gross margin78.5%
Valuation Snapshot
Bullrun's latest valuation model marks Electromed Inc as 8.3% undervalued; latest market cap is USD 231.66M; P/E is 21.3.
Peer valuation comparison
Latest P/E is 21.29x versus a Healthcare sector median of 24.61x (13.5% below).
Latest P/E is 21.29x versus a United States median of 23.85x (10.7% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | USD 73.78M | USD 11.30M | USD 8.37M | 78.5% | n/a | USD 20.45M | n/a | USD 53.98M |
| FY2025 | USD 64.00M | USD 7.54M | USD 11.13M | 78.1% | 0.85 | USD 15.29M | n/a | USD 43.21M |
| FY2024 | USD 54.72M | USD 5.15M | USD 8.78M | 76.3% | 0.58 | USD 16.08M | n/a | USD 44.55M |
| FY2023 | USD 48.07M | USD 3.17M | -USD 333.00K | 76.0% | 0.36 | USD 7.37M | n/a | USD 37.67M |
| FY2022 | USD 41.66M | USD 2.31M | -USD 2.11M | 75.5% | 0.26 | USD 8.15M | n/a | USD 34.17M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-09 | USD 231.66M | 21.3 | n/a | n/a |
| 2025 | 2025-12-31 | USD 241.10M | 28.3 | n/a | n/a |
| 2024 | 2024-12-31 | USD 252.85M | 38.9 | n/a | n/a |
| 2023 | 2023-12-29 | USD 93.63M | 29.5 | n/a | n/a |
| 2022 | 2022-12-30 | USD 89.01M | 47.7 | n/a | n/a |
| 2021 | 2021-12-31 | USD 110.93M | 59.1 | n/a | n/a |
About Electromed Inc
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally.
Related stock research
Other Healthcare stocks
Frequently asked questions
Is Electromed Inc overvalued or undervalued?
Bullrun's valuation model currently marks Electromed Inc as 8.3% undervalued.
What is Electromed Inc's market cap?
Electromed Inc's market capitalization is USD 231.66M.
What is Electromed Inc's P/E ratio?
Electromed Inc's price-to-earnings (P/E) ratio is 21.3.
What does Electromed Inc do?
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally.